Özlem Türeci
Founder presso BIONTECH SE
Patrimonio netto: 84 M $ in data 31/03/2024
Profilo
zlem Treci ha fondato BioNTech SE e Ganymed Pharmaceuticals AG. Attualmente, ricopre la posizione di Presidente di Ci3 Management UG, Presidente di Association For Cancer Immunotherapy e Chief Medical Officer di BioNTech SE. In passato ha occupato la posizione di Chief Executive & Medical Officer alla Ganymed Pharmaceuticals AG. Il Dr. Treci si è laureato alla Universitt des Saarlandes.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIONTECH SE
0.38% | 31/12/2023 | 913 247 ( 0.38% ) | 84 M $ | 31/03/2024 |
Posizioni attive di Özlem Türeci
| Società | Posizione | Inizio |
|---|---|---|
| BIONTECH SE | Founder | 02/06/2008 |
| Association For Cancer Immunotherapy | President | - |
| Ci3 Management UG | Chairman | - |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Corporate Officer/Principal | - |
Precedenti posizioni note di Özlem Türeci
| Società | Posizione | Fine |
|---|---|---|
Ganymed Pharmaceuticals AG
 Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Chief Executive Officer | - |
Formazione di Özlem Türeci
| Universität des Saarlandes | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIONTECH SE | Health Technology |
| Aziende private | 4 |
|---|---|
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Health Services |
| Association For Cancer Immunotherapy | |
| Ci3 Management UG |
- Borsa valori
- Insiders
- Özlem Türeci
